Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.

Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue

Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market OTCQB: DFCO subsidiary announces entry into the global weight loss drug market currently worth approximately $6 billion